Minimizing Legal Impact of Coronavirus for your Organization March 18, 2020 To help clients address legal questions sparked by the Coronavirus (COVID-19), Foster Swift has established a cross-disciplinary Coronavirus Task Force. Members of this task force are already helping clients assess and address business and operational issues presented by the virus. If your business, municipality or organization is facing potential legal issues caused by the spreading of the virus, we strongly encourage you to contact your Foster Swift attorney or one of the designated Coronavirus Task Force Coordinators: Mid-Michigan - John Mashni | 517.371.8257 | jmashni@fosterswift.com Southeast Michigan - Matthew Fedor | 248.785.4734 | mfedor@fosterswift.com West & Northern Michigan - Laura Genovich | 616.726.2238 | lgenovich@fosterswift.com The virus and public concern are escalating rapidly; prompt analysis by experienced legal counsel can help you minimize risk and attain the best outcome possible. Foster Swift’s offices are currently open and we are following best practices as provided by the Centers for Disease Control. However, should it become necessary to close our offices, our attorneys and staff are equipped and trained so we can continue to provide service virtually. On a related note, while there is no shortage of information provided by mainstream media, the resources below may be useful as you follow coverage related to the virus. Reliable news information sources regarding Coronavirus: Centers for Disease Control and Prevention
Michigan Department of Health & Human Services For the latest news, please visit "Press Releases" and "Resources." U.S. Government Guidelines: White Paper from U.S. Veterans Affairs
EEOC Guidelines – Pandemic Preparedness
Pandemic EEOC and ADA FAQs Foster Swift Articles: Coronavirus Task Force Services
Emergency Paid Sick Leave Act in the Families First Corona Virus Response Act
COVID-19 Legal Issues for Employers
FAQs from Employers
How Does the Coronavirus Impact Your Contracts
International Trade and COVID-19 |